CALLE DOCTOR FLEMING, 51 | 28036 MADRID, SPAIN
+34 91 3459395
info@oxonepi.com

OXON’s COVID-19 Research Programme

COVID 19

OXON's NOT-FOR-PROFIT INTERNATIONAL PROGRAMME FOR COVID-19

OXON is working with an international team of academics, and clinicians who treat COVID-19 patients, to help provide reliable evidence via non-randomised comparative studies of treatments for COVID-19 and prognostic factors to make decisions about pharmacological interventions in hospitalized COVID-19 patients.

Our activities include:

  • Non-randomised comparative retrospective cohort analyses of treatments in hospitalised COVID-19 patients in Spain
  • A ´real-time´ systematic review of non-randomised comparative studies of treatments for hospitalised patients with COVID-19 with requests for collaboration from study groups
  • Meta-analysis of non-randomised comparative studies of treatments in hospitalised COVID-19 patients
  • Seek to homogenise non-randomised comparative analyses of treatments in hospitalised COVID-19 patients where there are discrepant results between studies by collaboration with other study groups
  • Comparison of non-randomised comparative studies of treatments in hospitalised COVID-19 patients and RCTs, cumulatively as these studies are published

Our projects are registered in the EUPAS register and PROSPERO register.

To follow information on these projects, please visit covid19@oxonepi.com